help button home button Am J Pathol The FASEB Journal
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nartey, N.
Right arrow Articles by Banerjee, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nartey, N.
Right arrow Articles by Banerjee, D.

American Journal of Pathology, Vol 129, 177-182, Copyright © 1987 by American Society for Investigative Pathology


REGULAR ARTICLES

Immunohistochemical localization of metallothionein in human thyroid tumors

N Nartey, MG Cherian and D Banerjee
Department of Pathology, University of Western Ontario Health Sciences Center, London, Canada.

High levels of metallothionein (MT) are present in the developing mammalian liver; however, a remarkable decrease is observed during postnatal life after weaning. This developmental profile is similar to that of certain oncofetal gene products such as alpha-fetoprotein, which is used as a tumor marker. This study deals with the reexpression of MT genes in thyroid tumors. With an immunohistochemical method, the presence of MT was investigated in tissue sections of normal and neoplastic human thyroid glands. Tissue sections of 34 thyroid tumors and 10 normal human thyroid glands were studied by means of the peroxidase-antiperoxidase method. MT was localized in 31 of the thyroid gland tumors. MT was also present in two of the normal thyroid glands. These findings indicate that although high levels of MT are mainly found in the fetal liver, it may also be expressed actively in certain human thyroid neoplastic tissues, and occasionally in normal thyroid tissue.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
B.-H. Bay, R. Jin, J. Huang, and P.-H. Tan
Metallothionein as a prognostic biomarker in breast cancer.
Experimental Biology and Medicine, October 1, 2006; 231(9): 1516 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-G. Liu, L. Zhang, Y. Jiang, D. Chatterjee, C. M. Croce, K. Huebner, and L. Y.Y. Fong
Modulation of Gene Expression in Precancerous Rat Esophagus by Dietary Zinc Deficit and Replenishment
Cancer Res., September 1, 2005; 65(17): 7790 - 7799.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S.-K. Tai, O. J.-K. Tan, V. T.-K. Chow, R. Jin, J. L. Jones, P.-H. Tan, A. Jayasurya, and B.-H. Bay
Differential Expression of Metallothionein 1 and 2 Isoforms in Breast Cancer Lines with Different Invasive Potential: Identification of a Novel Nonsilent Metallothionein-1H Mutant Variant
Am. J. Pathol., November 1, 2003; 163(5): 2009 - 2019.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Hecht, D. Jung, V. V. Prabhu, P. J. Munson, M. P. Hoffman, and H. K. Kleinman
Metallothionein Promotes Laminin-1-induced Acinar Differentiation in Vitro and Reduces Tumor Growth in Vivo
Cancer Res., September 15, 2002; 62(18): 5370 - 5374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. P. A. Ebert, T. Günther, J. Hoffmann, J. Yu, S. Miehlke, H. U. Schulz, A. Roessner, M. Korc, and P. Malfertheiner
Expression of Metallothionein II in Intestinal Metaplasia, Dysplasia, and Gastric Cancer
Cancer Res., April 1, 2000; 60(7): 1995 - 2001.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
M. P. Waalkes, S. Rehm, and M. G. Cherian
Repeated Cadmium Exposures Enhance the Malignant Progression of Ensuing Tumors in Rats
Toxicol. Sci., March 1, 2000; 54(1): 110 - 120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.